Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie Kam

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 23, 2024
Identifying disruptive papers in pharmacy literature that changed clinical practice: 1954-2014Adan Z Becerra, Leslie Kam, Yoona Kim, et al.
Digestive Diseases (Basel, Switzerland)|August 4, 2021
ALT Levels in Treatment-Naive, Chronic Hepatitis B Patients with Concurrent Fatty Liver Disease: A US Nationwide StudyChristine Y Chang, Leslie Kam, Nolan Dang, et al.
Clinical and Molecular Hepatology|November 14, 2024
Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosisNicholas A Rouillard, Scott D Barnett, Xinrong Zhang, et al.
Alimentary Pharmacology & Therapeutics|May 2, 2024
Updates in characteristics and survival rates of cirrhosis in a nationwide cohort of real-world U.S. patients, 2003-2021Sally Tran, Biyao Zou, KeeSeok Lee, et al.
JAMA Network Open|December 8, 2022
Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United StatesVy H Nguyen, Leslie Kam, Yee Hui Yeo, et al.
Journal of Hepatocellular Carcinoma|December 11, 2023
Updates in Characteristics and Survival Rates of Hepatocellular Carcinoma in a Nationwide Cohort of Real-World US Patients, 2003-2021Sally Tran, Biyao Zou, Leslie Kam, et al.
JAMA Internal Medicine|December 12, 2022
Association of Direct-Acting Antiviral Therapy With Liver and Nonliver Complications and Long-term Mortality in Patients With Chronic Hepatitis CEiichi Ogawa, Nicholas Chien, Leslie Kam, et al.
Journal of Viral Hepatitis|January 20, 2025
Long-Term Immunity and Anamnestic Response Following Hepatitis B Vaccination: A Systematic Review and Meta-AnalysisHannah Ramrakhiani, Michael H Le, Leslie Kam, et al.
Gut|August 9, 2024
Synergistic association of sodium-glucose cotransporter-2 inhibitor and metformin on liver and non-liver complications in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver diseaseXianhua Mao, Xinrong Zhang, Leslie Kam, et al.
Hepatology International|August 30, 2019
Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C ConsortiumChung-Feng Huang, Etsuko Iio, Dae Won Jun, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 23, 2024
Identifying disruptive papers in pharmacy literature that changed clinical practice: 1954-2014Adan Z Becerra, Leslie Kam, Yoona Kim, et al.
Digestive Diseases (Basel, Switzerland)|August 4, 2021
ALT Levels in Treatment-Naive, Chronic Hepatitis B Patients with Concurrent Fatty Liver Disease: A US Nationwide StudyChristine Y Chang, Leslie Kam, Nolan Dang, et al.
Clinical and Molecular Hepatology|November 14, 2024
Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosisNicholas A Rouillard, Scott D Barnett, Xinrong Zhang, et al.
Alimentary Pharmacology & Therapeutics|May 2, 2024
Updates in characteristics and survival rates of cirrhosis in a nationwide cohort of real-world U.S. patients, 2003-2021Sally Tran, Biyao Zou, KeeSeok Lee, et al.
JAMA Network Open|December 8, 2022
Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United StatesVy H Nguyen, Leslie Kam, Yee Hui Yeo, et al.
Journal of Hepatocellular Carcinoma|December 11, 2023
Updates in Characteristics and Survival Rates of Hepatocellular Carcinoma in a Nationwide Cohort of Real-World US Patients, 2003-2021Sally Tran, Biyao Zou, Leslie Kam, et al.
JAMA Internal Medicine|December 12, 2022
Association of Direct-Acting Antiviral Therapy With Liver and Nonliver Complications and Long-term Mortality in Patients With Chronic Hepatitis CEiichi Ogawa, Nicholas Chien, Leslie Kam, et al.
Journal of Viral Hepatitis|January 20, 2025
Long-Term Immunity and Anamnestic Response Following Hepatitis B Vaccination: A Systematic Review and Meta-AnalysisHannah Ramrakhiani, Michael H Le, Leslie Kam, et al.
Gut|August 9, 2024
Synergistic association of sodium-glucose cotransporter-2 inhibitor and metformin on liver and non-liver complications in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver diseaseXianhua Mao, Xinrong Zhang, Leslie Kam, et al.
Hepatology International|August 30, 2019
Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C ConsortiumChung-Feng Huang, Etsuko Iio, Dae Won Jun, et al.
Pageof 2